+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Meningococcal Vaccine Market By Brand, By Type, By Age Group, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241368
  • Report
  • January 2021
  • Region: Europe
  • 77 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Bio-Med Pvt. Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
The Europe Meningococcal Vaccine Market is expected to witness market growth of 8% CAGR during the forecast period (2020-2026).

Meningococcal vaccines are perceiving a significant demand in line with a prominent increase in routine immunization. Increasing use of meningococcal vaccines for immunizing special risk groups, such as travellers, or military personnel is fueling gains in the market.

Moreover, non-profit organizations offering funds for research projects, healthcare professionals training, and providing information & support to patients. All these factors are anticipated to propel market growth. For example, the Meningitis Research Foundation has approved 161 research grants and invested about USD 28.0 million for scientific researches. Through this organization, people and expertise come together in order to face challenges in preventing meningitis.

In addition to it, the phase III vaccines in trials that are expected to be commercialized over the projected period, are anticipated to drive the market growth. For example, MenACYW, which is a conjugate vaccine manufactured by Sanofi, is in phase III clinical trial.

There is an increasing prevalence of various types of bacteria that cause meningococcal meningitis. The most common type of meningitis causing bacteria are A, B, C, W, Y, and type X that was more lately reported in Africa, continue to underline the criticality of more effective vaccine of meningococcal to be available in the coming years.

Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)

Scope of the Study

Market Segments covered in the Report:

By Brand
  • Bexsero
  • Trumenba
  • Nimenrix
  • Menactra
  • Menveo
  • Other Brands
By Type
  • Bivalent
  • Quadrivalent
  • Other Types
By Age Group
  • Infants (0 to 2 years)
  • Children (2 years & above)
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio-Med Pvt. Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Meningococcal Vaccine Market, by Brand
1.4.2 Europe Meningococcal Vaccine Market, by Type
1.4.3 Europe Meningococcal Vaccine Market, by Age Group
1.4.4 Europe Meningococcal Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Developments in Meningococcal Vaccine Market

Chapter 4. Europe Meningococcal Vaccine Market by Brand
4.1 Europe Bexsero Market by Country
4.2 Europe Trumenba Market by Country
4.3 Europe Nimenrix Market by Country
4.4 Europe Menactra Market by Country
4.5 Europe Menveo Market by Country
4.6 Europe Other Brands Market by Country

Chapter 5. Europe Meningococcal Vaccine Market by Type
5.1 Europe Bivalent Market by Country
5.2 Europe Quadrivalent Market by Country
5.3 Europe Other Types Market by Country

Chapter 6. Europe Meningococcal Vaccine Market by Age Group
6.1 Europe Children (2 years & above) and Adults Market by Country
6.2 Europe Infants(0 to 2 years) Market by Country

Chapter 7. Europe Meningococcal Vaccine Market by Country
7.1 Germany Meningococcal Vaccine Market
7.1.1 Germany Meningococcal Vaccine Market by Brand
7.1.2 Germany Meningococcal Vaccine Market by Type
7.1.3 Germany Meningococcal Vaccine Market by Age Group
7.2 UK Meningococcal Vaccine Market
7.2.1 UK Meningococcal Vaccine Market by Brand
7.2.2 UK Meningococcal Vaccine Market by Type
7.2.3 UK Meningococcal Vaccine Market by Age Group
7.3 France Meningococcal Vaccine Market
7.3.1 France Meningococcal Vaccine Market by Brand
7.3.2 France Meningococcal Vaccine Market by Type
7.3.3 France Meningococcal Vaccine Market by Age Group
7.4 Russia Meningococcal Vaccine Market
7.4.1 Russia Meningococcal Vaccine Market by Brand
7.4.2 Russia Meningococcal Vaccine Market by Type
7.4.3 Russia Meningococcal Vaccine Market by Age Group
7.5 Spain Meningococcal Vaccine Market
7.5.1 Spain Meningococcal Vaccine Market by Brand
7.5.2 Spain Meningococcal Vaccine Market by Type
7.5.3 Spain Meningococcal Vaccine Market by Age Group
7.6 Italy Meningococcal Vaccine Market
7.6.1 Italy Meningococcal Vaccine Market by Brand
7.6.2 Italy Meningococcal Vaccine Market by Type
7.6.3 Italy Meningococcal Vaccine Market by Age Group
7.7 Rest of Europe Meningococcal Vaccine Market
7.7.1 Rest of Europe Meningococcal Vaccine Market by Brand
7.7.2 Rest of Europe Meningococcal Vaccine Market by Type
7.7.3 Rest of Europe Meningococcal Vaccine Market by Age Group

Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Note: Product cover images may vary from those shown
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll